Legislation Allowing Conscientious Objection For Pharmacists Introduced In About Half Of State Legislatures This Year; None Were Approvedhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50407&nfid=nl

FDA Approves Nonprescription Sales Of Plan B For Women Over Age 18http://www.medicalnewstoday.com/medicalnews.php?newsid=50404&nfid=nl

Los Angeles Unified School District "Right" To Offer Merck's HPV Vaccine To Female Middle, Elementary School Students This Fall, Editorial Sayshttp://www.medicalnewstoday.com/medicalnews.php?newsid=50149&nfid=nl

Introgen Therapeutics, Inc. Presents Biomarker Data Predictive Of Therapeutic Efficacy At Annual Meeting Of The American Head And Neck Societyhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50112&nfid=nl

U.S. Food And Drug Administration Grants Expanded Indication For The NaviStar(R) ThermoCool(R) Catheter For Treatment Of Ventricular Tachycardiahttp://www.medicalnewstoday.com/medicalnews.php?newsid=50255&nfid=nl

Celldex Therapeutics Announces Presentation Of New EGFRvIII Expression And Clinical Data At The Targeted Immunotherapeutics And Vaccine Summithttp://www.medicalnewstoday.com/medicalnews.php?newsid=50338&nfid=nl

Exposure To Toxins Reduces The Effectiveness Of Immunisationhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50219&nfid=nl

How Immune Cells 'speak' To Each Other In Vivo Shown By First Studyhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50202&nfid=nl

Certain Key Connections Among Neurons Get Stronger When We Learn: MIT Provides First Evidence For Learning Mechanismhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50436&nfid=nl

Merger Of Nanowires And Neurons Could Boost Efforts To Measure And Understand Brain Activityhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50434&nfid=nl

New Insight Into How Neural Circuits Are Shaped By Experiencehttp://www.medicalnewstoday.com/medicalnews.php?newsid=50394&nfid=nl

System For Automated Analysis Of Behavior Developed By Forsyth Scientistshttp://www.medicalnewstoday.com/medicalnews.php?newsid=50325&nfid=nl

Neurobiological Technologies, Inc. Announces Completion Of Targeted U.S. Site Selection For Its First Viprinex(TM) (Ancrod Injection)http://www.medicalnewstoday.com/medicalnews.php?newsid=50432&nfid=nl

Corcept Therapeutics Announces Negative Results From The First Of Three Phase 3 Studies Evaluating CORLUX(R) For Psychotic Major Depressionhttp://www.medicalnewstoday.com/medicalnews.php?newsid=50516&nfid=nl